Safety and Nanotoxicity Aspects of Nanomedicines for Brain-Targeted Drug Delivery
2021 (English)In: Nanomedicines for Brain Drug Delivery / [ed] Javier O. Morales; Pieter J. Gaillard, Springer, 2021, p. 255-277Chapter in book (Refereed)
Abstract [en]
Nanotechnology for brain drug delivery comprises the promise for future possibilities of successful treatment in several central nervous system pathologies currently deficient of curative treatments, such as neurodegenerative disorders and malignant glioblastoma. Nevertheless, the neurotoxic effects exerted by several types of nanomaterials are the same as those involved in the pathology of neurodegeneration; thus it is important to have a deep knowledge of these mechanisms, so that a proper approach can be taken into consideration. On the other hand, cancer cells usually respond differently to normal cells, being this characteristic a potential advantage for brain cancer therapy. In this chapter we analyze the mechanisms behind neurotoxic effects, from a multidisciplinary perspective, aiming to highlight the disadvantages of nanomaterials for the development of brain-targeted nanocarriers.
Place, publisher, year, edition, pages
Springer, 2021. p. 255-277
Series
Neuromethods, ISSN 0893-2336, E-ISSN 1940-6045
Keywords [en]
Neurotoxicity, Neurodegeneration, Nanoparticle toxicity, Brain, Autophagy, Oxidative stress
National Category
Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:ltu:diva-86805DOI: 10.1007/978-1-0716-0838-8_10Scopus ID: 2-s2.0-85096538525OAI: oai:DiVA.org:ltu-86805DiVA, id: diva2:1587204
Note
ISBN för värdpublikation: 978-1-0716-0837-1; 978-1-0716-0838-8;
Forskningsfinansiär: ANID/FONDECYT Regular/1181689; ANID/PIA/ACT192144; ANID/FONDAP/15130011
2021-08-242021-08-242021-08-24Bibliographically approved